For a better experience of our website please update you web browser from IE11 to Microsoft Edge or an alternative modern browser such as Google Chrome. Thank you.

Jubilant Biosys Logo

Delivering the Added Dimension in Drug Discovery Services

Latest News

Jubilant snags $146.6M US contract to Double injectables production

14th June 2022

Jubilant HollisterStier continues to ride the manufacturing expansion wave generated by the COVID-19 business boom by snaring a $146.6 million contract from the U.S. government.

The contract, inked with several agencies that fall within the Department of Health and Human Services, will allow the Spokane, Washington-based CDMO to double its injectables filling capacity to meet current demand and prepare for any future pandemics.

Funded by the American Rescue Plan, the deal gives Jubilant a total of $193 million to pump into its manufacturing facility, the company said. It expects to complete the expansion funded by the contract by 2025.

View Detail